Recent depression updates: relevant presentations.
This review discusses several depression-relevant abstracts of posters and talks presented at the 2005 American College of Neuropsychopharmacology Annual Meeting and the 2006 Collegium Internationale Neuro-Psychopharmacologicum Meeting. Described are several novel psychopharmacologic treatments for major depressive disorder, some predictors of efficacy, and information relevant to understanding the activation of the hypothalamic-pituitary-adrenal axis in depression.
Janowsky
David S
DS
Department of Psychiatry, CB# 7175, University of North Carolina School of Medicine, Chapel Hill, NC 27599-7175, USA. David_Janowsky@med.unc.edu
D000928:Antidepressive Agents / Q000627:therapeutic use*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D009484:Neuropsychology; D011600:Psychopharmacology
D000928:Antidepressive Agents